Finance

Lists
Why is 060590 up 2,49%?
Dive Deeper
060590:KOSDAQ
CTC Bio Inc
2 675,00 KRW
+2,49%
(+65,00) 1D
5 ნოე, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 060590...
Open
2 610 KRW
High
2 745 KRW
Low
2 610 KRW
Mkt. cap
64,68 მლრდ.
Avg. vol.
38,19 ათ.
Volume
75,36 ათ.
P/E ratio
8,51
52-wk high
5 610 KRW
52-wk low
2 525 KRW
EPS
314 KRW
Shares outstanding
24,18 მლნ.
No. of employees
226
Open
2 610 KRW
High
2 745 KRW
Low
2 610 KRW
Mkt. cap
64,68 მლრდ.
Avg. vol.
38,19 ათ.
Volume
75,36 ათ.
P/E ratio
8,51
52-wk high
5 610 KRW
52-wk low
2 525 KRW
EPS
314 KRW
Shares outstanding
24,18 მლნ.
No. of employees
226
News stories
From web sources and news partners
24/7 Wall St.
24/7 Wall St.
·
16 წუთის წინ
This Year’s Worst S&P 500 Stock Just Got a Huge Reprieve
MarketWatch
MarketWatch
·
20 წუთის წინ
Bloom Energy’s stock is one of the S&P 500’s biggest losers amid fears of data-center delays
ABC News - Breaking News, Latest News and Videos
ABC News - Breaking News, Latest News and Videos
·
34 წუთის წინ
Dow plunges 1,200 points, Nasdaq into correction territory after midterm results stock rally
Axios
Axios
·
1 საათის წინ
Nasdaq plummets toward correction territory
About CTC Bio Inc
CEO-
Employees226
Founded1993
Headquarters-
SectorPharmaceutical industry
Industry-
Websitectcbio.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
31,80 მლრდ.
31,62 მლრდ.
34,44 მლრდ.
33,69 მლრდ.
Cost of goods sold
19,35 მლრდ.
18,91 მლრდ.
20,10 მლრდ.
20,42 მლრდ.
Cost of revenue
19,35 მლრდ.
18,91 მლრდ.
20,10 მლრდ.
20,42 მლრდ.
Research and development expenses
427,62 მლნ.
482,35 მლნ.
205,61 მლნ.
198,23 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,33 მლრდ.
10,29 მლრდ.
9,30 მლრდ.
8,87 მლრდ.
Operating expense
11,00 მლრდ.
11,20 მლრდ.
9,74 მლრდ.
9,48 მლრდ.
Total operating expenses
30,35 მლრდ.
30,11 მლრდ.
29,84 მლრდ.
29,89 მლრდ.
Operating income
1,45 მლრდ.
1,51 მლრდ.
4,60 მლრდ.
3,79 მლრდ.
Other non operating income
-33,35 მლნ.
-91,96 მლნ.
-55,25 მლნ.
-271,27 ათ.
EBT including unusual items
1,01 მლრდ.
-220,58 მლნ.
4,46 მლრდ.
3,49 მლრდ.
EBT excluding unusual items
943,91 მლნ.
-84,63 მლნ.
4,38 მლრდ.
3,38 მლრდ.
Income tax expense
656,08 მლნ.
-1,34 მლრდ.
955,92 მლნ.
887,77 მლნ.
Effective tax rate
64,69%
607,65%
21,45%
25,44%
Other operating expenses
109,16 მლნ.
92,32 მლნ.
34,12 მლნ.
202,89 მლნ.
Net income
310,40 მლნ.
1,10 მლრდ.
3,50 მლრდ.
2,60 მლრდ.
Net profit margin
0,98%
3,48%
10,16%
7,72%
Earnings per share
-
-
-
-
Interest and investment income
60,95 მლნ.
94,40 მლნ.
73,22 მლნ.
73,88 მლნ.
Interest expense
-604,79 მლნ.
-569,99 მლნ.
-553,03 მლნ.
-563,90 მლნ.
Net interest expenses
-543,84 მლნ.
-475,58 მლნ.
-479,80 მლნ.
-490,02 მლნ.
Depreciation and amortization charges
216,74 მლნ.
200,89 მლნ.
174,51 მლნ.
175,71 მლნ.
EBITDA
3,07 მლრდ.
3,11 მლრდ.
6,17 მლრდ.
5,38 მლრდ.
Gain or loss from assets sale
-94,40 მლნ.
-132,54 მლნ.
-78,68 მლნ.
-117,11 მლნ.
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები